Otros idiomas Bio-Techne Corporation

Acciones

TECH

US09073M1045

Biotecnología e investigación médica

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 08/06/2026			Después del cierre 01:49:12
52,65 ^USD	+1,27 %		55,54	+5,49 %

04/06	Bio-Techne Corporation y Refeyn anuncian un flujo de trabajo integrado para la caracterización de anticuerpos biespecíficos y biosimilares	CI
04/06	Bio-Techne y Refeyn presentan un nuevo flujo de trabajo para el análisis de anticuerpos	MT

Otros idiomas

05/06	Bio-Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
04/06	Bio-Techne Corporation and Refeyn Announces Integrated Workflow for Bispecific Antibody and Biosimilar Characterization
04/06	Bio-Techne, Refeyn Introduce Antibody Testing Workflow
04/06	Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
15/05	Bio-Techne's Planned Wilson Wolf Acquisition Underappreciated by Investors, RBC Says
12/05	Bio-Techne Insider Sold Shares Worth $320,386, According to a Recent SEC Filing
08/05	Analyst recommendations: Airbnb , Citigroup , The Walt Disney Company , Block, Cloudflare...
06/05	Bio-Techne pénalisé par le recul des financements académiques américains
06/05	Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026
06/05	Bio-Techne's Fiscal Q3 Adjusted Earnings, Revenue Fall
06/05	Bio-Techne misses revenue estimates as US academic funding cuts dent demand
06/05	Earnings Flash (TECH) Bio-Techne Corporation Reports Q3 Revenue $311.4M, vs. FactSet Est of $316.1M
06/05	Earnings Flash (TECH) Bio-Techne Corporation Posts Q3 Adjusted EPS $0.53 per Share, vs. FactSet Est of $0.53
06/05	Bio-Techne Declares Dividend
06/05	Bio-Techne Releases Third Quarter Fiscal 2026 Results
06/05	Bio-Techne Corporation announces Quarterly dividend, payable on May 29, 2026
04/05	Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
28/04	Cleo Diagnostics Starts Manufacturing, Development Program for Ovarian Cancer Test Kit Production; Shares Up 8%
16/04	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
16/04	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
16/04	Bio-Techne Corporation Introduces Streamlined Brand Architecture With Three Portfolio Brands
14/04	Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
26/03	Bio-Techne Advances Spatial Biology with Modular Expansion of COMET Suite
25/03	Bio-Techne Corporation Expands Comet Solution Portfolio with Addition of Spyre Focus Panels and Spyre Amplification Kits
25/03	Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite